Rocket Lab's Busiest Fortnight Yet Masks a Market Fixated on Neutron's Silence

Rocket Lab's stock stays below trendlines despite launch wins and contracts, as Neutron delays and Iridium deal keep investors cautious.

The gap between what Rocket Lab is doing and what its share price is saying has rarely been wider. Over roughly ten days in August, the company delivered a commercial satellite constellation order, launched its 93rd Electron mission, and won entry into a US Space Force network program alongside defense heavyweights — yet the stock sits well below its trendlines, weighed down by a single unresolved question: when will Neutron actually fly?

A Cadence That Speaks for Itself

The operational drumbeat is hard to dismiss. On August 15, Rocket Lab launched eight satellite platforms for MDA Space, the first tranche of a $143 million agreement covering 17 platforms destined to refresh the Globalstar constellation. Days later, between August 20 and 21, the 93rd Electron mission lifted off carrying an Earth-observation satellite for the Institute for Q-shu Pioneers of Space — the ninth such satellite delivered to that customer with a perfect 100 percent success record. Nine additional dedicated iQPS launches are already booked through 2030.

Sandwiched between those missions came a series of government wins. On August 17, the company was admitted to the Space Force's NITE-STAR program, a framework with a total ceiling of $981 million. The same day, Viasat selected Rocket Lab to build the satellite bus for the Protected Tactical SATCOM-Global program, tapping the geostationary configuration of the Lightning platform. A day later, the Space Force chose Rocket Lab for the Space Data Network Consortium, awarding $12 million in contracts to support a global military communications network — placing the company alongside Amazon LEO for Government, Lockheed Martin, Northrop Grumman, and York Space Systems.

Those wins followed an early-August award worth $397 million for Flatellite satellites under the Space-Based Airborne Moving Target Indicator program, plus a dedicated Neutron mission contracted by Kepler Communications. The pattern is unmistakable: government, commercial Earth observation, and satellite communications are all feeding the same pipeline.

The Market's Miserable Mood

None of this has moved the needle in the way one might expect. The stock closed Thursday at €58.00, up 2.1 percent, but that modest bounce follows a stretch of sustained weakness. The shares sit roughly 15 percent below their 50-day average of €68.57 and have fallen 6.8 percent over the past seven trading sessions. At €56.90 in recent trading, the stock is 17 percent below its 50-day average and 18 percent below its 200-day average — firmly beneath every meaningful trendline. The 52-week high of €133.80 remains a distant memory, with the stock still 57 percent off that mark.

The proximate cause is Neutron. The reusable rocket's delay has weighed on sentiment for roughly two weeks, during which the shares have shed about 18.2 percent. CEO Peter Beck has tried to reframe the debate, urging investors to focus less on Neutron's debut date and more on how quickly the company reaches its tenth Electron launch of the year. Progress on the "Hungry Hippo" fairing — additional heat shielding, control surfaces, avionics, and fluid systems — shows work is underway, but component progress is not the same as a held schedule.

The tension is visible in the volatility figures: 72 percent on a 30-day basis. This is a stock that can move violently in either direction on short notice.

Insider Sales Read as Routine

Adding to the noise, five executives sold shares this week worth a combined $5.49 million. CFO Adam Spice disposed of 9,677 shares on Thursday at a weighted average price of $69.63, roughly $674,000 in total. The five managers collectively sold 78,843 shares.

The market's muted reaction — the stock actually rose on the day — suggests investors are reading these as what they appear to be: routine tax-related disposals tied to vesting restricted stock units, not discretionary bets against the company. The executives still hold approximately 97.5 percent of their prior positions. Manager Frank Klein had also sold 45,692 shares for about $3.18 million on August 24.

Iridium: The Structural Prize

The more consequential storyline remains the planned acquisition of Iridium Communications. The Hart-Scott-Rodino antitrust waiting period expired on August 12, both companies have filed with the FCC to approve the transfer of Iridium's licenses, and the Form S-4 has been submitted to the SEC. Iridium shareholders are scheduled to vote on the merger on September 24.

Rocket Lab has also established a new equity agreement with Deutsche Bank Securities to fund part of the cash consideration and retire debt obligations, replacing the program set up in May 2026. The financing machinery is clearly being positioned for the transaction.

The second-quarter numbers frame the trade-off: $234 million in revenue, a backlog of $2.36 billion, a GAAP net loss of $49.3 million, and more than $1 billion in new contracts signed during and after the quarter. Growth and losses are advancing in lockstep — unremarkable for a company at this stage of scaling, but a persistent overhang until Neutron delivers.

The Longer Arc

Set against the twelve-month horizon, the picture brightens considerably. The stock is still up 43 percent from a year ago, and the strategic direction — the Mynaric acquisition, the founding of Rocket Lab Germany, the Iridium deal, the deepening defense footprint — points toward a company transforming from a launch provider into a vertically integrated space and communications group.

For now, the market is choosing to focus on what hasn't happened rather than what has. The operational evidence of the past two weeks suggests that may be a temporary condition, but with Neutron's timeline still undefined and the Iridium integration ahead, the stock's vulnerability to sharp moves in either direction is unlikely to subside soon.